HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
M V Catania Selected Research
M V Catania Research Topics
Disease
3
Fragile X Syndrome (Martin Bell Syndrome)
01/2021 - 09/2004
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
06/2001 - 01/2001
1
Brain Diseases (Brain Disorder)
05/2024
1
Autistic Disorder (Autism)
01/2021
1
Intellectual Disability (Idiocy)
01/2021
1
Gliosis
07/2017
1
Neurodegenerative Diseases (Neurodegenerative Disease)
07/2017
1
Drug Resistant Epilepsy
09/2006
1
Seizures (Absence Seizure)
08/2006
1
Hyperkinesis
09/2004
1
Cognitive Dysfunction
09/2004
1
Hyperalgesia
05/2002
1
Pain (Aches)
05/2002
1
Acute Pain
05/2002
1
Peripheral Nerve Injuries
05/2002
1
Chronic Pain
05/2002
Drug/Important Bio-Agent (IBA)
2
Fragile X Mental Retardation Protein
IBA
01/2021 - 05/2015
2
RNA-Binding Proteins (RNA-Binding Protein)
IBA
01/2021 - 05/2015
1
messenger ribonucleoprotein
IBA
05/2024
1
Proteins (Proteins, Gene)
FDA Link
01/2021
1
Peptides (Polypeptides)
IBA
07/2017
1
Endothelin-1 (Endothelin 1)
IBA
07/2017
1
Messenger RNA (mRNA)
IBA
05/2015
1
Glial Fibrillary Acidic Protein
IBA
09/2006
1
Member 1 Subfamily B ATP Binding Cassette Transporter
IBA
09/2006
1
4-Aminopyridine (4 Aminopyridine)
FDA Link
08/2006
1
Dopamine (Intropin)
FDA Link
Generic
09/2004
1
Acetylcarnitine (Alcar)
IBA
05/2002
1
LY 341495
IBA
05/2002
1
Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)
IBA
06/2001
1
Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)
IBA
01/2001
1
Glutamate Receptors (Glutamate Receptor)
IBA
01/2001
Therapy/Procedure
1
Analgesia
05/2002